Strait Access Technologies
Joshua Dehlen has a diverse work experience spanning various industries and roles. Joshua currently works as a Lead Engineer at Strait Access Technologies since January 2024. Prior to that, from January to December 2023, they served as a Mechanical Design and Operations Engineer at the same company.
Before joining Strait Access Technologies, Joshua Dehlen co-founded AFTERHRS EVENTS MANAGEMENT in April 2017. As a Co-Founder, their responsibilities included team management, venue procurement, event planning, merchandise stock management, business operations, marketing, and creative direction. Joshua was also hands-on in designing artwork, cinematography, and some photography for the events. Joshua'stenure at AFTERHRS EVENTS MANAGEMENT lasted from April 2017 to December 2023.
In 2022, Joshua Dehlen worked as an Assistant Manager at Motherson Group. Here, they carried on responsibilities from their previous role as a New Project Development Engineer and expanded their responsibilities to coordinate pre-production and production build support for the new Ford Ranger and VW Amarok vehicles. Joshua took the lead role in planning and providing budget estimations for new projects and had discussions with Ford Design Engineers. From May 2021 to March 2022, they served as a Mechanical Engineer for the Rosslyn Plant of MSSL RSA, primarily working on the new Ford Ranger and VW Amarok models, specializing in packaging engineering and project management.
During the period from September 2018 to May 2021, Joshua Dehlen worked as a Freelance Photographer/Cinematographer. Joshua used their skills in photography and cinematography for various projects. Earlier in their career, they gained work experience as a Sales Engineer at Test Dynamics Pty Ltd from January 2020 to April 2021.
Joshua Dehlen's work experience began in 2016 as a Vacation Student at the Council for Scientific and Industrial Research (CSIR). Joshua worked at the CSIR Built Environment Smart Trucks Division, focusing on vehicle data analysis for vehicle dynamics. This experience was spread over a two-year period, done during university holidays.
Joshua Dehlen obtained a Bachelor of Engineering in Mechanical Engineering from the University of Pretoria from 2014 to 2018. Prior to their university education, they received a National Senior Certificate from Pretoria Boys High School from 2009 to 2013. In addition to their formal education, Joshua has obtained additional certifications in Communication Skills for Modern Management and How to Handle Poor Performers from LinkedIn, with the year of completion not specified.
This person is not in any teams
Strait Access Technologies
Rheumatic Heart Disease (RHD) is an easily preventable type of heart disease caused by streptococcal bacteria. This bacteria is responsible for a common throat infection known as strep throat. When left untreated, a patient’s immune system can turn against his own heart while fighting the infection. This can lead to an acute inflammation of the heart accompanied by high fever (acute rheumatic fever). The inflammation can damage heart valves irreversibly. The disease mainly affects children between the ages 5 -15, and occurs approximately 14–28 days after symptoms of strep throat or scarlet fever appear. According to conservative and outdated WHO estimates, 15 million people are affected by the disease globally. Newer statistics argue that the number could be up to five times higher, at 60–75 million people worldwide. Rheumatic Heart Disease is much more prevalent among those living in developing countries, especially sub–Saharan Africa, due to limited access to quality healthcare and antibiotics. Rheumatic Heart Disease claims the lives of 1.4 million people per annum, with up to 70% of patients will dying before the age of 26. Although Rheumatic heart disease affects mainly the poor, all current heart valve technologies are focused on developed first world applications. These devices are highly sophisticated and make use of advanced monitoring equipment that requires highly specialised operators. Overall, neither skilled surgeons or cardiologists nor monitoring or imaging equipment and hospital facilities are available in the countries where Rheumatic Heart Disease is most prevalent. Due to this, of every 100 patients requiring heart valve replacement, only two patients are treated worldwide. With SAT’s technology this could change.